• Research Scientist II - Immunotherapy Integration Hub

    Job ID 2018-29526
    Area of Interest
    Research & Development
    Location Name
    Olive Lab at MPW
    FTE/Hours per pay period
    1.0 FTE (80 hours per bi-weekly pay periods)
    Work Status
    Regular
    Department
    Immunotherapy Integration Hub
    Shift
    Day Shift
  • Overview

    This is a unique type of position that requires significant individual initiative and motivation to learn and understand both existing and new scientific methods and knowledge. The Research Scientist will be given the opportunity and be responsible for conducting independent and creative research related to the overall mission of the laboratory. This is an ideal position for those considering graduate school in a related field or medical school in the near future (up to two years).

     

    Overall responsibilities include acquiring an in-depth understanding of the field in which they are working, and working with the PI, as well as independently, on the planning, design, execution, trouble-shooting, and interpretation of experiments; makes detailed observations, records data and presents results; assists post docs and fellows in the day-to-day activities and interprets experiments related to assigned projects. The Research Scientist will spend the majority of their time making contributions to on-going laboratory projects, requiring the ability to use independent judgment to address tasks and projects, and will identify and refine existing procedures and practices. The incumbent may also participate in the management of a small rodent colony.

    Requirements

    Required Education/Experience:

    - Bachelor’s Degree in biology, microbiology, immunology, molecular biology or biochemistry.

    -- Minimum to two (2) year’s experience in a related area/laboratory setting.

     

    Preferred:

    - Master’s Degree in biology, microbiology, immunology, molecular biology or biochemistry.

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed